Group 1 - Fosun Pharmaceutical (001288) announced the sale of its wholly-owned subsidiary, Henan Fosun Smart Energy Technology Co., Ltd., for 73 million yuan to Henan Xisheng Industrial Development Co., Ltd. [1] - The buyer, Henan Xisheng, is jointly controlled by Nanyang Industrial Investment Group (51% stake) and the Xichuan Finance Bureau (49% stake), focusing on property leasing, equipment leasing, and overseas engineering contracting [3]. - The subsidiary, Fosun Smart Energy, primarily operates photovoltaic power generation systems, with three installed capacities of approximately 6.09 MW, 6.38 MW, and 14.89 MW [3]. Group 2 - Fosun Pharmaceutical stated that its core business is pharmaceutical manufacturing and sales, and the photovoltaic business was initially intended to support internal power needs and generate external revenue, but it is not a core focus of the group [3]. - The sale aligns with the company's long-term strategy to streamline operations and focus on key business areas, and it will not significantly impact the company's daily pharmaceutical production and operations [3].
福森药业拟7300万元剥离光伏业务 聚焦医药核心主业